Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X:
“New in Biomedicines
ADC (mpMRI) + PSA at 6m after RT+ADT leads to better risk stratification in Prostate Cancer. Congrats to all authors!”
Title: Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer
Authors: Victor Duque-Santana, Julio Fernandez, Fernando López-Campos, Ana Diaz-Gavela, Manuel Recio, Luis L. Guerrero, Marina Peña, Sofia Sanchez, Israel J. Thuissard, Cristina Andreu-Vázquez, David Sanz-Rosa, Giulia Marvaso, Alfonso Gómez-Iturriaga, Thomas Zilli, Elia Del Cerro, Felipe Couñago
Read the Full Article.
More posts featuring Felipe Couñago.